A factor that affects the infant's physiological response to medication is:

School-age children (6–12 years) are in Erikson’s stage of industry vs inferiority, with increasing independence, curiosity, and peer-driven activity. Cognitive development often includes incomplete risk appraisal, leading to overconfidence, risk-taking behavior, and increased susceptibility to accidental injury.

Rationale:

A. Inability to read labels is not typical for school-age children. Basic literacy develops during this stage, and poisoning risk is more related to curiosity and improper supervision rather than reading inability alone.

B. Reduced interest in family opinions reflects adolescent psychosocial development, not school-age children. This stage is still strongly influenced by family guidance, so this option does not explain injury risk in this age group.

C. School-age children commonly overestimate physical abilities, leading to risky behaviors such as climbing, cycling, or sports activities beyond safe limits. This cognitive misjudgment increases exposure to trauma and accidental injury significantly.

D. School-age children are highly capable of safety education and learning rules. They are not too young to be taught hazard avoidance. Injury risk is not due to inability to understand danger but due to overconfidence and experimentation.

Intramuscular medication administration in toddlers requires consideration of muscle mass, vascular absorption, tissue tolerance, and risk of neuromuscular injury. The developing musculature of children under 2 years limits injectable volume capacity, making dose distribution and appropriate site selection essential for safe pharmacologic delivery.

Rationale:

A. A 3 mL intramuscular injection exceeds recommended tissue capacity for an 18-month-old child. Excessive volume increases risk of pain, muscle fiber damage, poor absorption, and local complications such as induration or nerve compression.

B. A maximum volume of 1 mL is recommended because toddler muscles have limited muscle bulk and reduced tissue distensibility. This volume promotes effective medication absorption while minimizing discomfort, tissue trauma, and leakage from the injection site.

C. A 5 mL injection is appropriate only for larger adult muscle groups with substantial muscular development. In toddlers, this volume can cause severe tissue stretching, impaired absorption, and increased risk of localized injury.

D. Although 2 mL may occasionally be tolerated in older children, it generally exceeds safe limits for most 18-month-olds. Smaller pediatric muscles cannot reliably accommodate this injection volume without increasing tissue irritation and procedural pain.